Skip to main content

Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment Shortage

Last Updated: March 30, 2022
Status: Current

Products Affected - Description
    • Neomycin and Polymyxin B Sulfates and Dexamethasone ophthalmic ointment, Perrigo, 3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, NDC 00574-4160-35
Reason for the Shortage
    • Bausch Health has neomycin/polymyxin B sulfates/dexamethasone ophthalmic ointment available.
    • Novartis has Maxitrol ointment available.
    • Perrigo did not provide a reason for the shortage.
    • Sandoz has neomycin/polymyxin B sulfates/dexamethasone ophthalmic ointment available.
Available Products
    • Maxitrol ophthalmic ointment, Novartis, 3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, NDC 00078-0771-01
    • Neomycin and Polymyxin B Sulfates and Dexamethasone ophthalmic ointment, Bausch Health, 3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, NDC 24208-0795-35
    • Neomycin and Polymyxin B Sulfates and Dexamethasone ophthalmic ointment, Sandoz, 3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, NDC 61314-0631-36

Estimated Resupply Dates

    • Perrigo has temporarily discontinued neomycin/polymyxin B/dexamethasone ophthalmic ointment in 3.5 gram tubes and the company cannot estimate a release date. All other presentations are available.

Updated

Updated March 30, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 17, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer